(1) The date of the notice of meeting.

(2) The date of the shareholder meeting.

(3) The indicative effective date of the transaction, with a statement to the effect that the date is not within the control of DBNZ and may change.

(1) The name and address of DBNZ.

(2) The names of every director of DBNZ.

The name of CIP.

A statement in the following form to be set out in a prominent position at the front of the notice of meeting:

All the terms and conditions of the transaction.

(1) A statement of the number, designation, and percentage of equity securities of any class of CIP that are held or controlled by—

• (a) DBNZ; and

• (b) any related company of DBNZ; and

• (c) any person acting jointly or in concert with DBNZ; and

• (d) any director of any of the persons described in paragraphs (a) to (c); and

• (e) any other person holding or controlling 5% or more of the class, to the knowledge of DBNZ.

(2) A statement that except for those persons who are specified in the statement made under subclause (1) as holding or controlling equity securities of CIP, no person referred to in clause 6(1)(a) to (d) holds or controls equity securities of CIP.

(1) If any of the persons referred to in clause 6(1)(a) to (d) has, during the 6-month period referred to in subclause (3), acquired or disposed of any equity securities of CIP, in respect of each such person—

• (a) the total number and the designation of each class of the equity securities acquired or disposed of; and

• (b) in the case of a single transaction on any day to which this subclause applies, the number of securities, the consideration per security, and the date of the transaction; and

• (c) in the case of multiple transactions on any day to which this subclause applies, the total number of securities acquired or disposed of on that day, in each class, and the weighted average consideration per security per class.

(2) If no person referred to in clause 6(1)(a)to (d) has, during the 6-month period referred to in subclause (3), acquired or disposed of any equity securities of CIP, a statement to that effect.

(3) The 6-month period referred to in subclauses (1) and (2) is the 6-month period ending on the date of the notice of meeting.

The names of any person who has agreed conditionally or unconditionally to vote in favour of the transaction and the material terms of the agreement.

(1) Confirmation from DBNZ that it has adequate resources to pay the subscription price for the acquisition of 19.90% of CIP.

(2) Statements to the effect that—

• (a) if the transaction is approved by the requisite majorities of shareholders and by the Court, the transaction will be binding on all shareholders; and

• (b) if shareholders object to the transaction, they will have the right to appear and be heard at the hearing for final orders.

Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between DBNZ or any associates of DBNZ, and CIP or any related company of CIP, in connection with, in anticipation of, or in response to, the transaction.

Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between DBNZ or any associate of DBNZ, and any of the directors or senior officers of CIP or of any related company of CIP (including particulars of any payment or other benefit proposed to be made or given by way of compensation for loss of office, or as to their remaining in or retiring from office) in connection with, in anticipation of, or in response to, the transaction.

Particulars of any agreement or arrangement made, or proposed to be made, under which CIP or any related company of CIP will give (directly or indirectly) financial assistance for the purpose of, or in connection with, the transaction.

A statement as to the general nature of any material changes likely to be made by DBNZ in respect of the business activities of CIP and its subsidiaries.

(1) Particulars of any restriction on the right to transfer equity securities to which the transaction relates that—

• (a) is contained in the constitution of CIP; and

• (b) has the effect of requiring the holders of the securities to offer the securities for purchase to members of CIP or to any other person before transferring the securities.

(2) If there is any such restriction, the arrangements (if any) being made to enable the securities to be transferred.

Particulars of any agreement or arrangement (whether legally enforceable or not) under which—

• (a) any existing holder of equity securities in CIP will or may receive in relation to, or as a consequence of, the transaction any additional consideration or other benefit over and above the consideration set out in the notice of meeting; or

• (b) any prior holder of equity securities in CIP will or may receive any consideration or other benefits as a consequence of the transaction.

A statement that there is only 1 class of securities subject to the transaction.

(1) A certificate in the following form signed by the persons specified in subclause (2):

(2) The persons referred to in subclause (1) are—

• (a) the chief executive officer and the chief financial officer of DBNZ, or their respective agents authorised in writing, or, if there is no chief executive officer or chief financial officer, the person or persons fulfilling those roles respectively, or their respective agents authorised in writing; and

• (b) 2 directors of DBNZ (or the sole director of DBNZ), not being the chief executive officer or the chief financial officer unless there is an insufficient number of other directors who must sign on behalf of the board of directors with the authority of a resolution of the board of directors.

(1) The date of the notice of meeting.

(2) The date of the shareholder meeting.

(3) The indicative effective date of the transaction, with a statement to the effect that the date is not within the control of CIP and may change.

A brief identification of the transaction to which the statement relates.

The name of CIP.

The names of the directors of CIP.

(1) The number, designation, and percentage of equity securities of any class of CIP that are held or controlled by—

• (a) each director or senior officer of CIP and their associates; and

• (b) any other person holding or controlling 5% or more of the class, to the knowledge of CIP.

(2) If any of the persons referred to in subclause (1) do not hold or control equity securities of CIP, a statement to that effect.

(3) The number of equity securities of CIP—

• (a) that have, during the period specified in subclause (5), been issued to the directors and senior officers of CIP or their associates; or

• (b) in which the directors and senior officers or their associates have, during the period specified in subclause (5), obtained a beneficial interest under any employee share scheme or other remuneration arrangement.

(4) The price at which the securities in subclause (3) were issued or provided.

(5) The period referred to in subclause (3) is the 2-year period that ends with the date of the notice of meeting.

(1) If any of the persons referred to in clause 5(1) has, during the 6-month period before the latest practicable date before the date of the notice of meeting, acquired or disposed of any equity securities of CIP,—

• (a) in respect of each such person, the total number and the designation of each class of the equity securities acquired or disposed of; and

• (b) in the case of a person referred to in—

  • (i) clause 5(1)(a), the number of securities, the consideration per security, and the date of each transaction to which this subclause applies; or

  • (ii) clause 5(1)(b),—

    • (A) in the case of a single transaction in any week to which this subclause applies, the number of securities, the consideration per security, and the week of each transaction; and

    • (B) in the case of multiple transactions in any week to which this subclause applies, the total number of securities acquired or disposed of in a week, in each class, and the weighted average consideration per security per class.

(2) If no person referred to in clause 5(1) has, during the 6-month period referred to in subclause (1), acquired or disposed of equity securities of CIP, a statement to that effect.

The name of every person referred to in clause 5(1)(a) who intends to vote in favour of the transaction, and the number of securities in respect of which the person intends to vote in favour.

(1) The number, designation, and percentage of equity securities of any class of DBNZ held or controlled by CIP and each director and senior officer of CIP and their associates.

(2) If none of the persons referred to in subclause (1) hold or control any equity securities of DBNZ, a statement to that effect.

(1) A statement of—

• (a) the number and designation of any equity securities of DBNZ that were acquired or disposed of by the persons referred to in clause 8 during the 6-month period referred to in clause 6(1); and

• (b) the consideration for, and the date of, every such transaction.

(2) If no such securities were acquired or disposed of, a statement to that effect.

Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between DBNZ or any associates of DBNZ, and CIP or any related company of CIP, in connection with, in anticipation of, or in response to, the transaction.

(1) Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between DBNZ or any associates of DBNZ, and any of the directors or senior officers of CIP or any related company of CIP (including particulars of any payment or other benefit proposed to be made or given by way of compensation for loss of office, or as to their remaining in or retiring from office) in connection with, in anticipation of, or in response to, the transaction.

(2) A statement as to whether any directors or senior officers of CIP are also directors or senior officers of DBNZ, or any related company of DBNZ, and to identify those persons.

Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between CIP or any related company of CIP, and any of the directors or senior officers or their associates of CIP or its related companies, under which a payment or other benefit may be made or given by way of compensation for loss of office, or as to their remaining in or retiring from office in connection with, in anticipation of, or in response to, the transaction.

(1) A statement as to whether any director or senior officer of CIP or their associates has an interest in any contract to which DBNZ, or any related company of DBNZ, is a party.

(2) Particulars of the nature of any interest referred to in subclause (1).

(3) The extent and (if capable of quantification) monetary value of any interest referred to in subclause (1).

(4) Subclause (3) does not apply if the contract was entered into in the ordinary course of business of DBNZ or its related company and on usual terms and conditions.

(1) A statement as to whether any person who, to the knowledge of the directors or the senior officers of CIP, holds or controls 5% or more of any class of equity securities of CIP has an interest in any material contract to which DBNZ, or any related company of DBNZ, is a party.

(2) Particulars of the nature of any interest referred to in subclause (1).

(3) The extent and (if capable of quantification) monetary value of any interest referred to in subclause (1).

(4) Subclause (3) does not apply if the contract was entered into in the ordinary course of business of DBNZ or its related company and on usual terms and conditions.

If, in the opinion of the directors of CIP, any information contained in Part A of Schedule A of the Additional Information section of the notice of meeting is incorrect or misleading, any additional information within the knowledge of CIP that would make the information contained in Part A of Schedule A of the Additional Information section of the notice of meeting correct or not misleading.

(1) Either—

• (a) a recommendation by the directors of CIP as to whether to vote for or against the transaction and the reasons for such recommendation; or

• (b) a statement that the directors of CIP are unable to make, or are not making, a recommendation and the reasons for not making a recommendation.

(2) If any of the directors dissent from a recommendation or from any statement under subclause (1)(b) made by the directors or abstain from making a recommendation or any statement under subclause (1)(b), their names and their reasons for dissenting or abstaining.

(3) If no recommendation is made, but all or any of the directors of CIP propose to make a recommendation, or to reconsider their decision not to make a recommendation, a statement to that effect.

(1) Particulars of any material agreement or arrangement (whether legally enforceable or not) of CIP and its related companies entered into as a consequence of, in response to, or in connection with, the transaction.

(2) A statement as to whether there are any negotiations underway as a consequence of, in response to, or in connection with, the transaction that relate to or could result in—

• (a) an extraordinary transaction, such as a merger, amalgamation, or reorganisation, involving CIP or any of its related companies; or

• (b) the acquisition or disposition of material assets by CIP or any of its related companies; or

• (c) an acquisition of equity securities by, or of, CIP or any related company of CIP; or

• (d) any material change in the equity securities on issue, or policy relating to distributions, of CIP.

(1) Details of the issued equity securities in CIP and the rights of the holders in respect of capital, distributions, and voting.

(2) The material terms of equity securities that are options or rights to acquire equity securities.

(1) A statement that CIP shareholders are entitled to obtain from CIP a copy of the most recent annual report of CIP.

(2) A copy of the most recent half-yearly report of CIP, if any, since the annual report referred to in subclause (1).

(3) A copy of the most recent interim report of CIP, if any, since the annual report referred to in subclause (1), or, if a copy of a half-yearly report has been disclosed under subclause (2), a copy of any interim report of CIP relating to a period after that half-yearly report, if any.

(4) All material changes in the financial or trading position, or prospects, of CIP since the annual report referred to in subclause (1) or a statement that there are no known material changes.

(5) Any other information about the assets, liabilities, profitability, and financial affairs of CIP that could reasonably be expected to be material to the making of a decision by the CIP shareholders to vote for or against the transaction.

(6) For the purposes of this clause,—

(1) The identity of the independent adviser who has provided a report on the merits of the transaction and a copy of the adviser's full report.

(2) The full report must include—

• (a) a statement of the qualifications and expertise of the adviser; and

• (b) a statement that the adviser has no conflict of interest that could affect the adviser's ability to provide an unbiased report.

If any information provided in the notice of meeting and accompanying information (other than the information contained in Part A of Schedule A and Part A of Schedule B of the Additional Information section of the notice of meeting) refers to a valuation of any asset,—

• (a) the date of the valuation, the identity of the valuer, and a summary of the valuation that discloses the basis of computation and the key assumptions on which the valuation is based; and

• (b) an address or addresses where copies of the valuation are available for inspection and a statement that a copy of the valuation will be sent to any CIP shareholder on request.

If any information provided in the notice of meeting and accompanying information (other than the information contained in Part A of Schedule A and Part A of Schedule B of the Additional Information section of the notice of meeting) refers to prospective financial information, the principal assumptions on which the prospective financial information is based.

All the information that CIP has as to the number of equity securities in CIP that have been disposed of in the 12 months ending on the latest practicable date before the date on which the notice of meeting is sent to shareholders, and the consideration for those dispositions.

Any other information (other than the information contained in Part A of Schedule A and Part A of Schedule B of the Additional Information section of the notice of meeting) that could reasonably be expected to be material to the making of a decision by the CIP shareholders to vote for or against the transaction.

(1) A statement that the contents of Part B of Schedule A of the Additional Information section of the notice of meeting have been approved by the board of directors of CIP.

(2) If any of the directors of CIP do not approve of the statement, their names and their reasons for not approving.

(1) A certificate in the following form signed by the persons specified in subclause (2):

(2) The persons referred to in subclause (1) are—

• (a) the chief executive officer and the chief financial officer of CIP, or their respective agents authorised in writing, or, if there is no chief executive officer or chief financial officer, the person or persons fulfilling those roles respectively, or their respective agents authorised in writing; and

• (b) 2 directors of CIP (or the sole director of CIP), not being the chief executive officer or the chief financial officer unless there is an insufficient number of other directors who must sign on behalf of the board of directors with the authority of a resolution of the board of directors.

(1) The date of the notice of meeting.

(2) The date of the shareholder meeting.

(3) The indicative effective date of the transaction, with a statement to the effect that the date is not within the control of CIPH and may change.

(1) The name and address of CIPH.

(2) The names of every director of CIPH.

The name of CIP.

A statement in the following form to be set out in a prominent position at the front of the notice of meeting:

All the terms and conditions of the transaction.

(1) A statement of the number, designation, and percentage of equity securities of any class of CIP that are held or controlled by—

• (a) CIPH; and

• (b) any related company of CIPH; and

• (c) any person acting jointly or in concert with CIPH; and

• (d) any director of any of the persons described in paragraphs (a) to (c); and

• (e) any other person holding or controlling 5% or more of the class, to the knowledge of CIPH.

(2) A statement that except for those persons who are specified in the statement made under subclause (1) as holding or controlling equity securities of CIP, no person referred to in clause 6(1)(a) to (d) holds or controls equity securities of the target company.

(1) If any of the persons referred to in clause 6(1)(a) to (d) has, during the 6-month period referred to in subclause (3), acquired or disposed of any equity securities of CIP, in respect of each such person—

• (a) the total number and the designation of each class of the equity securities acquired or disposed of; and

• (b) in the case of a single transaction on any day to which this subclause applies, the number of securities, the consideration per security, and the date of the transaction; and

• (c) in the case of multiple transactions on any day to which this subclause applies, the total number of securities acquired or disposed of on that day, in each class, and the weighted average consideration per security per class.

(2) If no person referred to in clause 6(1)(a) to (d) has, during the 6-month period referred to in subclause (3), acquired or disposed of any equity securities of CIP, a statement to that effect.

(3) The 6-month period referred to in subclauses (1) and (2) is the 6-month period ending on the date of the notice of meeting.

The names of any person who has agreed conditionally or unconditionally to vote in favour of the transaction and the material terms of the agreement.

(1) Confirmation by CIPH of how the consideration for the CIP shares acquired by CIPH is to be provided to shareholders.

(2) Statements to the effect that—

• (a) if the transaction is approved by the requisite majorities of shareholders and by the Court, the transaction will be binding on all shareholders; and

• (b) if shareholders object to the transaction, they will have the right to appear and be heard at the hearing for final orders.

Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between CIPH or any associates of CIPH, and CIP or any related company of CIP, in connection with, in anticipation of, or in response to, the transaction.

Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between CIPH or any associates of CIPH, and any of the directors or senior officers of CIP or of any related company of CIP (including particulars of any payment or other benefit proposed to be made or given by way of compensation for loss of office, or as to their remaining in or retiring from office) in connection with, in anticipation of, or in response to, the transaction.

Particulars of any agreement or arrangement made, or proposed to be made, under which CIP or any related company of CIP will give (directly or indirectly) financial assistance for the purpose of, or in connection with, the transaction.

A statement as to the general nature of any material changes likely to be made by CIPH in respect of the business activities of CIP and its subsidiaries.

(1) Particulars of any restriction on the right to transfer equity securities to which the transaction relates that—

• (a) is contained in the constitution of CIP; and

• (b) has the effect of requiring the holders of the securities to offer the securities for purchase to members of CIP or to any other person before transferring the securities.

(2) If there is any such restriction, the arrangements (if any) being made to enable the securities to be transferred.

Particulars of any agreement or arrangement (whether legally enforceable or not) under which—

• (a) any existing holder of equity securities in CIP will or may receive in relation to, or as a consequence of, the transaction any additional consideration or other benefit over and above the consideration set out in the notice of meeting; or

• (b) any prior holder of equity securities in CIP will or may receive any consideration or other benefits as a consequence of the transaction.

A statement that there is only one class of securities subject to the transaction.

(1) A certificate in the following form signed by the persons specified in subclause (2):

(2) The persons referred to in subclause (1) are 2 directors of CIP Holdings Limited (or the sole director of CIP Holdings Limited).

(1) The date of the notice of meeting.

(2) The date of the shareholder meeting.

(3) The indicative effective date of the transaction, with a statement to the effect that the date is not within the control of CIP and may change.

A brief identification of the transaction to which the statement relates.

The name of CIP.

The names of the directors of CIP.

(1) The number, designation, and percentage of equity securities of any class of CIP held or controlled by—

• (a) each director or senior officer of CIP and their associates; and

• (b) any other person holding or controlling 5% or more of the class, to the knowledge of CIP.

(2) If any of the persons referred to in subclause (1) do not hold or control equity securities of CIP, a statement to that effect.

(3) The number of equity securities of CIP—

• (a) that have, during the period specified in subclause (5), been issued to the directors and senior officers of CIP or their associates; or

• (b) in which the directors and senior officers or their associates have, during the period specified in subclause (5), obtained a beneficial interest under any employee share scheme or other remuneration arrangement.

(4) The price at which the securities in subclause (3) were issued or provided.

(5) The period referred to in subclause (3) is the 2-year period that ends with the date of the notice of meeting.

(1) If any of the persons referred to in clause 5(1) has, during the 6-month period before the latest practicable date before the date of the notice of meeting, acquired or disposed of any equity securities of CIP,—

• (a) in respect of each such person, the total number and the designation of each class of the equity securities acquired or disposed of; and

• (b) in the case of a person referred to in—

  • (i) clause 5(1)(a), the number of securities, the consideration per security, and the date of each transaction to which this subclause applies; or

  • (ii) clause 5(1)(b),—

    • (A) in the case of a single transaction in any week to which this subclause applies, the number of securities, the consideration per security, and the week of each transaction; and

    • (B) in the case of multiple transactions in any week to which this subclause applies, the total number of securities acquired or disposed of in a week, in each class, and the weighted average consideration per security per class.

(2) If no person referred to in clause 5(1) has, during the 6-month period referred to in subclause (1), acquired or disposed of equity securities of CIP, a statement to that effect.

The name of every person referred to in clause 5(1)(a) who intends to vote in favour of the transaction, and the number of securities in respect of which the person intends to vote in favour.

(1) The number, designation, and percentage of equity securities of any class of CIPH held or controlled by CIP and each director and senior officer of CIP and their associates.

(2) If none of the persons referred to in subclause (1) hold or control any equity securities of CIPH, a statement to that effect.

(1) A statement of—

• (a) the number and designation of any equity securities of CIPH that were acquired or disposed of by the persons referred to in clause 8 during the 6-month period referred to in clause 6(1); and

• (b) the consideration for, and the date of, every such transaction.

(2) If no such securities were acquired or disposed of, a statement to that effect.

Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between CIPH or any associates of CIPH, and CIP or any related company of CIP, in connection with, in anticipation of, or in response to, the transaction.

(1) Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between CIPH or any associates of CIPH, and any of the directors or senior officers of CIP or any related company of CIP (including particulars of any payment or other benefit proposed to be made or given by way of compensation for loss of office, or as to their remaining in or retiring from office) in connection with, in anticipation of, or in response to, the transaction.

(2) A statement as to whether any directors or senior officers of CIP are also directors or senior officers of CIPH, or any related company of CIPH, and to identify those persons.

Particulars of any agreement or arrangement (whether legally enforceable or not) made, or proposed to be made, between CIP or any related company of CIP, and any of the directors or senior officers or their associates of CIP or its related companies, under which a payment or other benefit may be made or given by way of compensation for loss of office, or as to their remaining in or retiring from office in connection with, in anticipation of, or in response to, the transaction.

(1) A statement as to whether any director or senior officer of CIP or their associates has an interest in any contract to which CIPH, or any related company of CIPH, is a party.

(2) Particulars of the nature of any interest referred to in subclause (1).

(3) The extent and (if capable of quantification) monetary value of any interest referred to in subclause (1).

(4) Subclause (3) does not apply if the contract was entered into in the ordinary course of business of CIPH or its related company and on usual terms and conditions.

(1) A statement as to whether any person who, to the knowledge of the directors or the senior officers of CIP, holds or controls 5% or more of any class of equity securities of CIP has an interest in any material contract to which CIPH, or any related company of CIPH, is a party.

(2) Particulars of the nature of any interest referred to in subclause (1).

(3) The extent and (if capable of quantification) monetary value of any interest referred to in subclause (1).

(4) Subclause (3) does not apply if the contract was entered into in the ordinary course of business of CIPH or its related company and on usual terms and conditions.

If, in the opinion of the directors of CIP, any information in Part A of Schedule B of the Additional Information section of the notice of meeting is incorrect or misleading, any additional information within the knowledge of CIP that would make the information in Part A of Schedule B of the Additional Information section of the notice of meeting correct or not misleading.

(1) Either—

• (a) a recommendation by the directors of CIP whether to vote for or against the transaction and the reasons for such recommendation; or

• (b) a statement that the directors of CIP are unable to make, or are not making, a recommendation and the reasons for not making a recommendation.

(2) If any of the directors dissent from a recommendation or from any statement under subclause (1)(b) made by the directors or abstain from making a recommendation or any statement under subclause (1)(b), their names and their reasons for dissenting or abstaining.

(3) If no recommendation is made, but all or any of the directors of CIP propose to make a recommendation, or to reconsider their decision not to make a recommendation, a statement to that effect.

(1) Particulars of any material agreement or arrangement (whether legally enforceable or not) of CIP and its related companies entered into as a consequence of, in response to, or in connection with, the transaction.

(2) A statement as to whether there are any negotiations underway as a consequence of, in response to, or in connection with, the transaction that relate to or could result in—

• (a) an extraordinary transaction, such as a merger, amalgamation, or reorganisation, involving CIP or any of its related companies; or

• (b) the acquisition or disposition of material assets by CIP or any of its related companies; or

• (c) an acquisition of equity securities by, or of, CIP or any related company of CIP; or

• (d) any material change in the equity securities on issue, or policy relating to distributions, of CIP.

(1) Details of the issued equity securities in CIP and the rights of the holders in respect of capital, distributions, and voting.

(2) The material terms of equity securities that are options, or rights to acquire, equity securities.

(1) A statement that CIP shareholders are entitled to obtain from CIP a copy of the most recent annual report of CIP.

(2) A copy of the most recent half-yearly report of CIP, if any, since the annual report referred to in subclause (1).

(3) A copy of the most recent interim report of CIP, if any, since the annual report referred to in subclause (1), or, if a copy of a half-yearly report has been disclosed under subclause (2), a copy of any interim report of CIP relating to a period after that half-yearly report, if any.

(4) All material changes in the financial or trading position, or prospects, of CIP since the annual report referred to in subclause (1) or a statement that there are no known material changes.

(5) Any other information about the assets, liabilities, profitability, and financial affairs of CIP that could reasonably be expected to be material to the making of a decision by the CIP shareholders to vote for or against the transaction.

(6) For the purposes of this clause,—

(1) The identity of the independent adviser who has provided a report on the merits of the transaction and a copy of the adviser's full report.

(2) The full report must include—

• (a) a statement of the qualifications and expertise of the adviser; and

• (b) a statement that the adviser has no conflict of interest that could affect the adviser's ability to provide an unbiased report.

If any information provided in the notice of meeting and accompanying information (other than the information contained in Part A of Schedule A and Part A of Schedule B of the Additional Information section of the notice of meeting) refers to a valuation of any asset,—

• (a) the date of the valuation, the identity of the valuer, and a summary of the valuation that discloses the basis of computation and the key assumptions on which the valuation is based; and

• (b) an address or addresses where copies of the valuation are available for inspection and a statement that a copy of the valuation will be sent to any CIP shareholder on request.

If any information provided in the notice of meeting and accompanying information (other than the information contained in Part A of Schedule A and Part A of Schedule B of the Additional Information section of the notice of meeting) refers to prospective financial information, the principal assumptions on which the prospective financial information is based.

All the information that CIP has as to the number of equity securities in CIP that have been disposed of in the 12 months ending on the latest practicable date before the date on which the notice of meeting is sent to shareholders, and the consideration for those dispositions.

Any other information (other than the information contained in Part A of Schedule A and Part A of Schedule B) that could reasonably be expected to be material to the making of a decision by the CIP shareholders to vote for or against the transaction.

(1) A statement that the contents of Part B of Schedule B of the Additional Information section of the notice of meeting have been approved by the board of directors of CIP.

(2) If any of the directors of CIP do not approve of the statement, their names and their reasons for not approving.

(1) A certificate in the following form signed by the persons specified in subclause (2):

(2) The persons referred to in subclause (1) are—

• (a) the chief executive officer and the chief financial officer of CIP, or their respective agents authorised in writing, or, if there is no chief executive officer or chief financial officer, the person or persons fulfilling those roles respectively, or their respective agents authorised in writing; and

• (b) 2 directors of CIP (or the sole director of CIP), not being the chief executive officer or the chief financial officer unless there is an insufficient number of other directors who must sign on behalf of the board of directors with the authority of a resolution of the board of directors.